SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (1104)6/18/1998 10:07:00 AM
From: Jim B  Read Replies (2) | Respond to of 5402
 
<<Hope springs eternal...the point here is how very difficult it is to get a blood substitute product through the FDA trials. >>

Well, if it's hard.. it hasn't been a problem for Dr. Drees..

from today's news:

<<Drees, who has been in the forefront of the artificial blood products field for more than 20 years, was the president and CEO of the only company to have obtained FDA approval for a synthetic
blood product to date. >>

jim



To: Andrew H who wrote (1104)6/18/1998 10:15:00 AM
From: eRM Solutions  Read Replies (1) | Respond to of 5402
 
And the ONLY CEO/DR to do this is our DR Drees, hmmmmmm. But then again Andrew you definitely know much more then the SCIENTISTS at Battelle.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News